Evidence map›Paper›PMID 34566958›Full record

ArticleFrontiers in immunology2021

Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression

Yue Qiu, Yirui Cao, Guowei Tu, Jiawei Li, Ying Su, Fang Fang, Xuepeng Zhang, Jing Cang, Ruiming Rong, Zhe Luo

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. T-Cell Remodeling in Renal Fibrosis: From Acute Injury to Chronic Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Nuclear Factor I-B Delays Liver Fibrosis by Inhibiting Chemokine Ligand 5 Transcription.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yue QiuDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yirui CaoDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
Guowei TuDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Jiawei LiDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
Ying SuDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Fang FangDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Xuepeng ZhangDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Jing CangShanghai Key Laboratory of Organ Transplantation, Shanghai, China.
Ruiming RongDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhe LuoDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhongshan Hospital · CNSun Yat-sen University · CNShanghai Institute of Organic Chemistry · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Renal fibrosis is inevitable in all progressive chronic kidney diseases (CKDs) and represents a serious public health problem. Immune factors contribute to the progression of renal fibrosis. Thus, it is very possible that immunosuppression cells, such as myeloid-derived suppressor cells (MDSCs), could bring benefits to renal fibrosis. Herein, this study investigated the antifibrotic and reno-protective effect of MDSCs and the possible mechanisms. Methods: Murine and cell models of unilateral ureter obstruction (UUO) renal fibrosis were used. Bone marrow-induced MDSCs and granulocyte-macrophage colony-stimulating factor (GM-CSF) were pretreated before surgery. Kidney weight, pathological injury, extracellular matrix deposition, and epithelial-mesenchymal transition progression were examined. Transforming growth factor (TGF)-β1)/Smad/Snail signaling pathway involvement was investigated through Western blotting and quantitative PCR (qPCR). Accumulation of MDSC, CD4+ T cell, regulatory T (Treg), and T helper 1 (T Results: Conclusion:

Indexed as

AnimalsChemokine CCL5Disease ProgressionFibrosisMaleMiceMice, Inbred C57BLMyeloid-Derived Suppressor CellsReceptors, CCR5Renal Insufficiency, ChronicChemokine CCL5Receptors, CCR5CCL5CCR5migrationmyeloid-derived suppressor cellsrenal fibrosis

Identifiers

PMID34566958
PMCPMC8460909
OpenAlexW3199129840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.